News

J.P. Morgan Sees Strong Q2 for Eli Lilly, Maintains Overweight Rating
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
MoneySense on MSN2h
Single-stock ETFs: Approach with caution
Whether for income or day trading, these ETFs are more complex and potentially risky products than they first appear. Buyer ...
StockStory.org on MSN19h
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Organon ...
Zacks Investment Research on MSN9h
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...